Benchimol D, Dartigues J F, Benchimol H, Bordier P, Duplàa C, Couffinhal T, Bonnet J
Service de Cardiologie et Maladies Vasculaires, Hôpital Cardiologique, Pessac, France.
Eur J Clin Invest. 1995 Dec;25(12):935-41. doi: 10.1111/j.1365-2362.1995.tb01970.x.
There is scant information on the progression of coronary artery disease in non-dilated sites in the months following percutaneous transluminal coronary angioplasty (PTCA) or on its relationship with restenosis. To assess the incidence of this progression and its relationship with restenosis at various times after PTCA, the authors selected 371 consecutive patients who had undergone a first successful PTCA for angina on native coronaries followed by a repeat angiographic study. The angiograms were analysed by a computer-assisted method; progression was defined as a 20% decrease in diameter and restenosis as a 30% decrease in diameter or a return to > 50% stenosis. The relationship between progression and restenosis was analysed in the whole population and then, using the Mantel-Haenszel chi-square test, in two subgroups: patients with a stable clinical state, who were restudied routinely and those whose worsened state had prompted repeat angiography. The relationship was assessed at different times between angioplasty and the repeat angiography. Progression was observed in 80 patients (22%) and restenosis in 155 patients (42%). There was a highly significant relationship between progression and restenosis in the total population (chi 2 = 26.4, odds ratio = 3.9 and P < 0.0003) and in the group of patients that were routinely restudied (chi 2 = 31.6, odds ratio = 5.3 and P < 0.0001), but not in the group of patients in whom restudy was performed because of clinical worsening (chi 2 = 0.13, odds ratio = 1.5 and P = NS). With respect to the length of follow-up, in the total population the relationship was significant only at 6 and 7 months (P < 0.0001), and in the group receiving a routine restudy only at 4-5 and 6-7 months (P < 0.001). Progression in non-dilated sites appeared to be strongly and transiently linked with restenosis, suggesting that PTCA may enhance both restenosis and progression over a short period.
关于经皮腔内冠状动脉成形术(PTCA)后数月内非扩张部位冠状动脉疾病的进展情况及其与再狭窄的关系,目前的信息很少。为了评估PTCA后不同时间点这种进展的发生率及其与再狭窄的关系,作者选取了371例连续的患者,这些患者首次因心绞痛成功接受了PTCA治疗,随后进行了再次血管造影研究。血管造影采用计算机辅助方法进行分析;进展定义为直径减少20%,再狭窄定义为直径减少30%或狭窄程度恢复至>50%。在总体人群中分析了进展与再狭窄的关系,然后使用Mantel-Haenszel卡方检验在两个亚组中进行分析:临床状态稳定且常规进行复查的患者,以及因病情恶化而促使再次进行血管造影的患者。在血管成形术和再次血管造影之间的不同时间点评估这种关系。80例患者(22%)出现进展,155例患者(42%)出现再狭窄。总体人群中进展与再狭窄之间存在高度显著的关系(卡方 = 26.4,比值比 = 3.9,P < 0.0003),在常规复查的患者组中也是如此(卡方 = 31.6,比值比 = 5.3,P < 0.0001),但在因临床恶化而进行复查的患者组中并非如此(卡方 = 0.13,比值比 = 1.5,P = 无显著性差异)。关于随访时间,在总体人群中,这种关系仅在6个月和7个月时具有显著性(P < 0.0001),在接受常规复查的组中仅在4 - 5个月和6 - 7个月时具有显著性(P < 0.001)。非扩张部位的进展似乎与再狭窄密切且短暂相关,这表明PTCA可能在短期内增强再狭窄和进展。